Lemtrada and Ritalin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lemtrada (alemtuzumab) and Ritalin (methylphenidate hydrochloride). Common drug interactions include gait disturbance among females and hypothyroidism among males.
The phase IV clinical study analyzes what interactions people have when they take Lemtrada and Ritalin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Lemtrada?
Lemtrada has active ingredients of alemtuzumab. eHealthMe is studying from 8,317 Lemtrada users. Check the latest studies of Lemtrada.
What is Ritalin?
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.
18 people who take Lemtrada and Ritalin together, and have interactions are studied.

What are the common drug interactions of Lemtrada and Ritalin, by gender? *:
female:
- Gait disturbance
- Hypersomnia (excessive daytime sleepiness (eds))
- Pneumonia
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Leukocyturia (presence of white blood cells in urine)
- Lymphocyte count decreased
- Lymphocyte percentage decreased
- Monocyte percentage increased
- Neutrophil percentage increased
- Urine abnormality
male:
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Tonsil cancer
- Feeling drunk
What are the common drug interactions of Lemtrada and Ritalin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Back pain
- Erythema (redness of the skin)
- Gait disturbance
- Headache (pain in head)
- Muscular weakness (muscle weakness)
- Rash
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Leukocyturia (presence of white blood cells in urine)
- Lymphocyte count decreased
- Lymphocyte percentage decreased
40-49:
- Back pain
- Balance disorder
- Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)
- Blood pressure increased
- Bradycardia (abnormally slow heart action)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac failure
- Cd4 lymphocytes decreased
- Cd4 lymphocytes increased
- Chest pain
50-59:
- Death
60+:
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 44.44%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 33.33%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 16.67%
- Pain: 3 people, 16.67%
- Gait Disturbance: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Lemtrada and Ritalin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lemtrada and Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lemtrada:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lemtrada and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ritalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on alemtuzumab and methylphenidate hydrochloride (the active ingredients of Lemtrada and Ritalin, respectively), and Lemtrada and Ritalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rozerem vs. Xanax, side effect and effectiveness comparison - 6 seconds ago
- Drug interactions of Acyclovir and Vitamin C - 9 seconds ago
- Levetiracetam and Paraesthesia for Women aged 20-29 - 28 seconds ago
- Could Children'S Advil cause Thrombocytopenia? - 30 seconds ago
- Drug interactions of Acetylsalicylic Acid and Gabitril - 35 seconds ago
- Aleve vs. Darvon-N, side effect and effectiveness comparison - 38 seconds ago
- Sickle Cell Anemia and Migraine - 40 seconds ago
- Drug interactions of Vicodin and Pravastatin Sodium - 40 seconds ago
- Drug interactions of Cardura and Erythromycin - 59 seconds ago
- Dermatitis Exfoliative and drugs of ingredients of imatinib mesylate - a minute ago